Human Genome Epidemiology Literature Finder
|
Records 1 - 18 (of 18 Records) |
| Query Trace: Breast Neoplasms and PIK3R1[original query] |
|---|
| Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms. Oncotarget 2014 May 5 (9): 2349-54. Wheler Jennifer J, Parker Barbara A, Lee Jack J, Atkins Johnique T, Janku Filip, Tsimberidou Apostolia M, Zinner Ralph, Subbiah Vivek, Fu Siqing, Schwab Richard, Moulder Stacy, Valero Vicente, Schwaederle Maria, Yelensky Roman, Miller Vincent A, Stephens M Philip J, Meric-Bernstam Funda, Kurzrock Razel |
| Genetic variants in the mTOR pathway and interaction with body size and weight gain on breast cancer risk in African-American and European American women. Cancer causes & control : CCC 2016 08 27 (8): 965-76. Cheng Ting-Yuan David, Shankar Jyoti, Zirpoli Gary, Roberts Michelle R, Hong Chi-Chen, Bandera Elisa V, Ambrosone Christine B, Yao So |
| Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer. PloS one 2017 12 (7): e0180192. Pascual Tomas, Apellániz-Ruiz María, Pernaut Cristina, Cueto-Felgueroso Cecilia, Villalba Pablo, Álvarez Carlos, Manso Luis, Inglada-Pérez Lucia, Robledo Mercedes, Rodríguez-Antona Cristina, Ciruelos E |
| The prognostic effects of somatic mutations in ER-positive breast cancer. Nature communications 2018 Sep 9 (1): 3476. Griffith Obi L, Spies Nicholas C, Anurag Meenakshi, Griffith Malachi, Luo Jingqin, Tu Dongsheng, Yeo Belinda, Kunisaki Jason, Miller Christopher A, Krysiak Kilannin, Hundal Jasreet, Ainscough Benjamin J, Skidmore Zachary L, Campbell Katie, Kumar Runjun, Fronick Catrina, Cook Lisa, Snider Jacqueline E, Davies Sherri, Kavuri Shyam M, Chang Eric C, Magrini Vincent, Larson David E, Fulton Robert S, Liu Shuzhen, Leung Samuel, Voduc David, Bose Ron, Dowsett Mitch, Wilson Richard K, Nielsen Torsten O, Mardis Elaine R, Ellis Matthew |
| Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients. Nature communications 2018 Apr 9 (1): 1357. Chen Li, Yang Liu, Yao Ling, Kuang Xia-Ying, Zuo Wen-Jia, Li Shan, Qiao Feng, Liu Yi-Rong, Cao Zhi-Gang, Zhou Shu-Ling, Zhou Xiao-Yan, Yang Wen-Tao, Shi Jin-Xiu, Huang Wei, Hu Xin, Shao Zhi-Mi |
| Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer. Frontiers in oncology 2020 9 10 1475. Khoury Katia, Tan Antoinette R, Elliott Andrew, Xiu Joanne, Gatalica Zoran, Heeke Arielle L, Isaacs Claudine, Pohlmann Paula R, Schwartzberg Lee S, Simon Michael, Korn W Michael, Swain Sandra M, Lynce Fili |
| Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 Mar . Beca Francisco, Krings Gregor, Chen Yunn-Yi, Hosfield Elizabeth M, Vohra Poonam, Sibley Richard K, Troxell Megan L, West Robert B, Allison Kimberly H, Bean Gregory |
| Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses. Breast cancer research : BCR 2020 Oct 22 (1): 107. Fumagalli Caterina, Ranghiero Alberto, Gandini Sara, Corso Federica, Taormina Sergio, De Camilli Elisa, Rappa Alessandra, Vacirca Davide, Viale Giuseppe, Guerini-Rocco Elena, Barberis Massi |
| Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data. Pathology oncology research : POR 2021 8 27 1609789. Hua Yu, Gao Lihong, Li Xiao |
| PHLPP2 gene L1016S (rs61733127) and PIK3R1 gene Met326Ile (rs3730089) polymorphisms are associated with the risk of colon and breast cancers. Nucleosides, nucleotides & nucleic acids 2021 7 40 (7): 767-778. Daneshvar Gelareh, Boostani Saghar, Moghanibashi Mehdi, Mohamadynejad Pari |
| Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics. Journal of Cancer 2021 6 12 (14): 4408-4417. Xiao Weikai, Zhang Guochun, Chen Bo, Chen Xiaoqing, Wen Lingzhu, Lai Jianguo, Li Xuerui, Li Min, Liu Hao, Liu Jing, Han-Zhang Han, Lizaso Analyn, Liao Ni |
| The Correlation of Mutations and Expressions of Genes within the PI3K/Akt/mTOR Pathway in Breast Cancer-A Preliminary Study. International journal of molecular sciences 2021 3 22 (4): . Ko?odziej Przemys?aw, Nico? Marcin, Krawczyk Pawe? A, Bogucki Jacek, Karczmarczyk Agnieszka, Zalewski Daniel, Kubrak Tomasz, Ko?odziej El?bieta, Makuch-Kocka Anna, Madej-Czerwonka Barbara, P?achno Bartosz J, Kocki Janusz, Bogucka-Kocka An |
| PI3K activation promotes resistance to eribulin in HER2-negative breast cancer. British journal of cancer 2021 3 124 (9): 1581-1591. Gris-Oliver Albert, Ibrahim Yasir H, Rivas Martín A, García-García Celina, Sánchez-Guixé Mònica, Ruiz-Pace Fiorella, Viaplana Cristina, Pérez-García José M, Llombart-Cussac Antonio, Grueso Judit, Parés Mireia, Guzmán Marta, Rodríguez Olga, Anton Pilar, Cozar Patricia, Calvo Maria Teresa, Bruna Alejandra, Arribas Joaquín, Caldas Carlos, Dienstmann Rodrigo, Nuciforo Paolo, Oliveira Mafalda, Cortés Javier, Serra Viole |
| Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences. Cells 2021 12 10 (12): . Serio Pedro Adolpho de Menezes Pacheco, de Lima Pereira Gláucia Fernanda, Katayama Maria Lucia Hirata, Roela Rosimeire Aparecida, Maistro Simone, Folgueira Maria Aparecida Azevedo Koi |
| Evaluation of cfDNA as an early detection assay for dense tissue breast cancer. Scientific reports 2022 May 12 (1): 8458. Barbirou Mouadh, Miller Amanda A, Gafni Erik, Mezlini Amel, Zidi Asma, Boley Nathan, Tonellato Peter |
| Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer. Experimental & molecular medicine 2023 7 . Ji-Yeon Kim, Sabin Park, Eun Yoon Cho, Jeong Eon Lee, Hae Hyun Jung, Byung Joo Chae, Seok Won Kim, Seok Jin Nam, Soo Youn Cho, Yeon Hee Park, Jin Seok Ahn, Semin Lee, Young-Hyuck |
| TERT Promoter Mutation c.-124C>T Commonly Occurs in Low-Grade Fibromatosis-like Metaplastic Breast Carcinoma. Archives of pathology & laboratory medicine 2023 3 . Webersinke Gerald, Burghofer Jonathan, Malli Theodora, Rammer Melanie, Jahn Stephan Wenzel, Niendorf Axel, Tavassoli Fattaneh A, Moinfar Far |
| Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers. Breast cancer research and treatment 2023 12 . Melody A Cobleigh, Kayla Viets Layng, Elizabeth Mauer, Brett Mahon, Adam J Hockenberry, Abde M Abukhde |
- Page last reviewed:Feb 1, 2024
- Content source: